SCHEMBL6047529

SCHEMBL6047529

C=CCC1=C(CC=C)C(=O)C(OC)=C(OC)C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 1/20 0.40
▸ ALDH1A1 P00352 6/20 0.39
▸ MAPT P10636 5/20 0.39
▸ TDP1 Q9NUW8 4/20 0.39
▸ THRB P10828 1/20 0.39
▸ LMNA P02545 4/20 0.38
▸ CYP3A4 P08684 5/20 0.38
▸ KDM4E B2RXH2 4/20 0.38
▸ HPGD P15428 4/20 0.38
▸ TP53 P04637 3/20 0.38
▸ ALOX15 P16050 3/20 0.38
▸ CYP2D6 P10635 2/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ MAP2K7 O14733 1/20 0.38
▸ GMNN O75496 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ CDC25A P30304 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11874455 0.88 IDO1 (0.51) IDO1ALDH1A1MAPTTDP1THRB
SCHEMBL3186176 0.77 CYP3A4 (0.35) CYP3A4POLB
SCHEMBL7104703 0.75 ELANE (0.31) MAPTTDP1LMNACYP3A4CYP2D6
SCHEMBL27904725 0.75 CYP3A4 (0.33) CYP3A4
SCHEMBL16231160 0.69 MAPT (0.50) IDO1ALDH1A1MAPTTDP1THRB
SCHEMBL8942748 0.68 CASP3 (0.48) IDO1ALDH1A1MAPTTDP1THRB
SCHEMBL7188407 0.68 LMNA (0.33) LMNAALOX5PTGS1
SCHEMBL14894680 0.68 MAPT (0.67) IDO1ALDH1A1MAPTTDP1THRB
SCHEMBL3420496 0.68 MAPT (0.58) IDO1ALDH1A1MAPTTDP1THRB
SCHEMBL4318927 0.66 LMNA (0.61) IDO1ALDH1A1MAPTTDP1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7044945-B2 Prevention of regression in thermal ciliary muscle tendinoplasty SAND BRUCE J 2006-05-16 — — US disclosed
US-20040093046-A1 Prevention of regression in thermal ciliary muscle tendinoplasty SAND BRUCE J 2004-05-13 — — US disclosed
EP-0808103-A4 PROTEIN HYDROXYLATION INHIBITORS FOR FIBROPROLIFERATIVE DISORDERS CORNELL RES FOUNDATION INC (US) 2001-10-17 — — EP disclosed
WO-2000074648-A2 PREVENTION OF REGRESSION IN REFRACTIVE KERATOPLASTY SUNRISE TECHNOLOGIES INTERNATIONAL, INC. (US) 2000-12-14 — — WO disclosed
US-6080766-A ADMINISTERING TO A PATIENT AN EFFECTIVE AMOUNT OF A HYDROXYPYRROLIDONE COMPOUND TO SUPPRESS THE FORMATION OF COLLAGEN-LIKE SUBSTANCES OR BIOSYNTHESIS OF PROCOLLAGEN CORNELL RESEARCH FOUNDATION, INC. (US) 2000-06-27 — — US disclosed
US-6046219-A ADMINISTERING TO THE PATIENT FOR TREATING THE CONDITIONS MEDIATED BY COLLAGEN FORMATION TOGETHER WITH CELL PROLIFERATION A HYDROXYPYRIDINE DERIVATIVE CORNELL RESEARCH FOUNDATION, INC. (US) 2000-04-04 — — US disclosed
US-5965585-A SUPPRESSING FORMATION OF COLLAGEN AND COLLAGEN-LIKE SUBSTANCES OR BIOSYNTHESIS OF PROCOLLAGEN IN LIVING SYSTEMS BY ADMINISTERING A HYDROXYPYRIDONE COMPOUND ENZYME INHIBITOR OF PROTEIN HYDROXYLASE; ANTISCARRING AGENTS CORNELL RESEARCH FOUNDATION, INC. (US) 1999-10-12 — — US disclosed
US-5965586-A Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation CORNELL RESEARCH FOUNDATION, INC. (US) 1999-10-12 — — US disclosed
US-5789426-A SUPPRESSION FORMATION OF COLLAGEN CORNELL RESEARCH FOUNDATION, INC. (US) 1998-08-04 — — US disclosed
EP-0808103-A1 PROTEIN HYDROXYLATION INHIBITORS FOR FIBROPROLIFERATIVE DISORDERS CORNELL RESEARCH FOUNDATION, INC. (US) 1997-11-26 — — EP disclosed
WO-1996022021-A1 PROTEIN HYDROXYLATION INHIBITORS FOR FIBROPROLIFERATIVE DISORDERS CORNELL RESEARCH FOUNDATION, INC. (US) 1996-07-25 — — WO disclosed
Send feedback